Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Industry report shows bleak 2013 for med tech industry
Fierce Medical Devices
Tuesday, March 11, 2014 - 11:15am
tags:
devices, M&A, R&D
Kythera buys back Bayer's stake in PhIII chin-fat therapy in $84M deal
Fierce Biotech
Tuesday, March 11, 2014 - 11:13am
tags:
Kythera, Bayer, ATX-101, double chin
[video] Controversy grows over potent pain drug Zohydro
CNBC
Tuesday, March 11, 2014 - 11:11am
tags:
Zohydro, Zogenix, painkillers, hydrocodone
Philips' ventilator recall gets FDA's highest-risk status
Mass Device
Tuesday, March 11, 2014 - 10:44am
tags:
Trilogy Ventilators, Respironics, recalls, Philips, FDA, devices
Catalysts That Could Push Top Biotech Stocks Even Higher
Wall St 24/7
Tuesday, March 11, 2014 - 10:04am
tags:
biotech, Biogen Idec, Gilead Sciences, Illumina, United Therapeutics, Vertex Pharmaceuticals
Cerulean pitches $75M IPO to give its cancer drug another shot
Fierce Biotech
Tuesday, March 11, 2014 - 8:45am
tags:
IPOs, Cerulean, CRLX101
Ranbaxy scrambles for ingredients to make generic Nexium
Yahoo/Reuters
Tuesday, March 11, 2014 - 8:42am
tags:
generics, Nexium, Ranbaxy, AstraZeneca
US court denies Myriad Genetics' motion to block rival
Reuters
Tuesday, March 11, 2014 - 8:40am
tags:
Myriad Genetics, Ambry Genetics, diagnostics
FDA Says Sponsors of Chronic Fatigue Syndrome Drugs can Rely on Patient-Reported Outcomes
Regulatory Focus
Tuesday, March 11, 2014 - 8:39am
tags:
drug development, chronic fatigue syndrome, FDA
Sanofi, UCB enter small-molecule drug development deal for immune-mediated diseases
First Word Pharma
Tuesday, March 11, 2014 - 8:37am
tags:
Sanofi, UCB Pharmaceuticals, small molecule drugs, drug development
This Startup Wants To Become The Google Of Drugs
Business Insider
Tuesday, March 11, 2014 - 8:35am
tags:
RxRevu
Massachusetts gives $1M to biotech partners
Boston Herald, MA
Tuesday, March 11, 2014 - 8:29am
tags:
Massachusetts, biotech
Does Pharma's Emphasis On External Sourcing Of Drugs Represent A Strategic Shift Away From Internal Research?
Forbes
Tuesday, March 11, 2014 - 8:23am
tags:
R&D
Bayer, Onyx Report Primary Endpoint of Phase 3 Study Results of NEXAVAR as Adjuvant Treatment for Patients with Liver Cancer Who Have Undergone Surgery or Local Ablation was Not Met
Bloomberg
Tuesday, March 11, 2014 - 8:22am
tags:
Bayer, ONYX Pharmaceuticals, Nexavar, liver cancer
Pfizer Breast-Cancer Drug To Show If It's For Real
Investors.com
Monday, March 10, 2014 - 7:51pm
tags:
Pfizer, breast cancer, CDK 4/6 inhibitors, palbociclib
US halts plans to alter Medicare drug coverage rules
First Word Pharma
Monday, March 10, 2014 - 5:17pm
tags:
Medicare, coverage
La Jolla Pharma's drug improves kidney function in mid-stage study
Yahoo/Reuters
Monday, March 10, 2014 - 5:07pm
tags:
La Jolla Pharmaceutical, GCS-100, chronic kidney disease
Germany OKs Northwest Bio brain cancer drug, shares soar
Yahoo/Reuters
Monday, March 10, 2014 - 5:06pm
tags:
Germany, glioblastoma multiforme, DCVax, Northwest Biotherapeutics
InterMune Rises on Takeover Rumour
Yahoo/Zacks.com
Monday, March 10, 2014 - 5:05pm
tags:
M&A, InterMune, Sanofi, Esbriet, Boehringer Ingelheim, Novartis
GlaxoSmithKline Ups Its Stake in Indian Pharmaceutical Unit
Wall St Cheat Sheet
Monday, March 10, 2014 - 4:06pm
tags:
GSK, India

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.